276 related articles for article (PubMed ID: 20211017)
21. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
22. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
Miyoshi Y; Ando A; Egawa C; Taguchi T; Tamaki Y; Tamaki H; Sugiyama H; Noguchi S
Clin Cancer Res; 2002 May; 8(5):1167-71. PubMed ID: 12006533
[TBL] [Abstract][Full Text] [Related]
23. Modulation of HJURP (Holliday Junction-Recognizing Protein) levels is correlated with glioblastoma cells survival.
Valente V; Serafim RB; de Oliveira LC; Adorni FS; Torrieri R; Tirapelli DP; Espreafico EM; Oba-Shinjo SM; Marie SK; Paçó-Larson ML; Carlotti CG
PLoS One; 2013; 8(4):e62200. PubMed ID: 23638004
[TBL] [Abstract][Full Text] [Related]
24. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Pliarchopoulou K; Kalogeras KT; Kronenwett R; Wirtz RM; Eleftheraki AG; Batistatou A; Bobos M; Soupos N; Polychronidou G; Gogas H; Samantas E; Christodoulou C; Makatsoris T; Pavlidis N; Pectasides D; Fountzilas G
Cancer Chemother Pharmacol; 2013 Jan; 71(1):245-55. PubMed ID: 23096218
[TBL] [Abstract][Full Text] [Related]
26. High Wilms' tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer.
Qi XW; Zhang F; Yang XH; Fan LJ; Zhang Y; Liang Y; Ren L; Zhong L; Chen QQ; Zhang KY; Zang WD; Wang LS; Zhang Y; Jiang J
Oncol Rep; 2012 Oct; 28(4):1231-6. PubMed ID: 22797561
[TBL] [Abstract][Full Text] [Related]
27. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer.
Habashy HO; Rakha EA; Ellis IO; Powe DG
Breast Cancer Res Treat; 2013 Jul; 140(2):307-16. PubMed ID: 23887673
[TBL] [Abstract][Full Text] [Related]
28. Expression profiling of ion channel genes predicts clinical outcome in breast cancer.
Ko JH; Ko EA; Gu W; Lim I; Bang H; Zhou T
Mol Cancer; 2013 Sep; 12(1):106. PubMed ID: 24053408
[TBL] [Abstract][Full Text] [Related]
29. Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.
Rody A; Karn T; Ruckhäberle E; Müller V; Gehrmann M; Solbach C; Ahr A; Gätje R; Holtrich U; Kaufmann M
Breast Cancer Res Treat; 2009 Feb; 113(3):457-66. PubMed ID: 18340528
[TBL] [Abstract][Full Text] [Related]
30. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X
Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990
[TBL] [Abstract][Full Text] [Related]
31. Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.
Tozlu-Kara S; Roux V; Andrieu C; Vendrell J; Vacher S; Lazar V; Spyratos F; Tubiana-Hulin M; Cohen P; Dessen P; Lidereau R; Bièche I
J Mol Endocrinol; 2007 Oct; 39(4):305-18. PubMed ID: 17909269
[TBL] [Abstract][Full Text] [Related]
32. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
[TBL] [Abstract][Full Text] [Related]
33. Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy.
Liu RZ; Graham K; Glubrecht DD; Germain DR; Mackey JR; Godbout R
Am J Pathol; 2011 Mar; 178(3):997-1008. PubMed ID: 21356353
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.
Widschwendter A; Tonko-Geymayer S; Welte T; Daxenbichler G; Marth C; Doppler W
Clin Cancer Res; 2002 Oct; 8(10):3065-74. PubMed ID: 12374673
[TBL] [Abstract][Full Text] [Related]
35. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients.
Moureau-Zabotto L; Ricci S; Lefranc JP; Coulet F; Genestie C; Antoine M; Uzan S; Lotz JP; Touboul E; Lacave R
Br J Cancer; 2006 Feb; 94(4):473-80. PubMed ID: 16434992
[TBL] [Abstract][Full Text] [Related]
37. The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival.
Broustas CG; Ross JS; Yang Q; Sheehan CE; Riggins R; Noone AM; Haddad BR; Seillier-Moiseiwitsch F; Kallakury BV; Haffty BG; Clarke R; Kasid UN
Clin Cancer Res; 2010 Jun; 16(11):2939-48. PubMed ID: 20400521
[TBL] [Abstract][Full Text] [Related]
38. Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer.
Pavlou MP; Dimitromanolakis A; Diamandis EP
Proteomics; 2013 Apr; 13(7):1083-95. PubMed ID: 23386393
[TBL] [Abstract][Full Text] [Related]
39. Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients.
Yan Y; Skliris GP; Penner C; Chooniedass-Kothari S; Cooper C; Nugent Z; Blanchard A; Watson PH; Myal Y; Murphy LC; Leygue E
Breast Cancer Res; 2009; 11(5):R67. PubMed ID: 19740422
[TBL] [Abstract][Full Text] [Related]
40. Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.
Lanigan F; Gremel G; Hughes R; Brennan DJ; Martin F; Jirström K; Gallagher WM
Breast Cancer Res; 2010; 12(4):R59. PubMed ID: 20682066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
